Delivering Value To Those We Serve

Overview

Recent News

Date Title and Summary
Toggle Summary Assertio Therapeutics to Participate in Upcoming Investor Conferences
LAKE FOREST, Ill. , Oct. 17, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, today announced that members of senior management will participate at the following investor conferences.
Toggle Summary Assertio Therapeutics to Report Third-Quarter 2018 Financial Results After The Close of Markets on Thursday, November 8, 2018
LAKE FOREST, Ill. , Oct. 08, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ:ASRT) today announced that it will release third-quarter 2018 financial results on Thursday, November 8, 2018 , after the close of markets. Following the announcement, the Company will host a conference call
Toggle Summary Assertio Therapeutics to Present at the 16th Annual Morgan Stanley Global Healthcare Conference
LAKE FOREST, Ill. , Sept. 05, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, today announced that members of senior management will participate at the 16 th Annual Morgan Stanley Global Healthcare

Recent SEC Filings

Filing date Description Form Filing Group View

Optional form for the registration of securities to be sold to the public by small business issuers

SB-2
Registration Statements
View HTML

Pre-effective amendment to an SB-2 filing

SB-2/A
Registration Statements
View HTML

Registration of certain classes of securities 12(b) of the Securities Exchange Act

8-A12B
Registration Statements
View HTML

Substantive changes from or additions to a prospectus previously filed

424A
Registration Statements
View HTML

Pre-effective amendment to an SB-2 filing

SB-2/A
Registration Statements
View HTML

IR Contact

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com
 

Independent Registered Public Accounting Firm

Ernst & Young LLP
Palo Alto, CA
 

Investor Relations Contact

John B. Thomas
SVP, Investor Relations & Corporate Communications
jthomas@assertiotx.com